View in EDS HTML Full Text PDF Full Text

Direct comparison of efficacy of combining ivermectin versus five first-line chemotherapy drugs with recombinant methioninase against colon-cancer cells.

Saved in:
Bibliographic Details
Title: Direct comparison of efficacy of combining ivermectin versus five first-line chemotherapy drugs with recombinant methioninase against colon-cancer cells.
Authors: Kim J; AntiCancer Inc., San Diego, CA, United States.; Department of Surgery, University of California, San Diego, San Diego, CA, United States.; Department of Surgery, Chungnam National University College of Medicine, Daejeon, Republic of Korea., Han Q; AntiCancer Inc., San Diego, CA, United States., Li S; AntiCancer Inc., San Diego, CA, United States., Kang BM; AntiCancer Inc., San Diego, CA, United States.; Department of Surgery, University of California, San Diego, San Diego, CA, United States., Miyashi Y; AntiCancer Inc., San Diego, CA, United States.; Department of Surgery, University of California, San Diego, San Diego, CA, United States., Ishiguro T; AntiCancer Inc., San Diego, CA, United States.; Department of Surgery, University of California, San Diego, San Diego, CA, United States., Bouvet M; Department of Surgery, University of California, San Diego, San Diego, CA, United States., Hoffman RM; AntiCancer Inc., San Diego, CA, United States.; Department of Surgery, University of California, San Diego, San Diego, CA, United States.
Source: Frontiers in oncology [Front Oncol] 2026 Jun 03; Vol. 16, pp. 1807785. Date of Electronic Publication: 2026 Jun 03 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2234-943X
DOI:10.3389/fonc.2026.1807785